Over-the-Counter Emergency Contraception: The First Year

September 2007
National NOW Times;Fall2007, Vol. 39 Issue 2, p10
The article discusses the challenges women face following the approval by the U.S. Food and Drug Administration of the non-prescription sale of emergency contraception for women 18-years-old and above. However, those below 18-years-old will still have to get prescription, which the author believes would be a barrier to the prevention of unwanted pregnancies. Reportedly, religious and political groups urge pharmacists to refuse to fill prescriptions for contraception, which are required by law.


Related Articles

  • FDA delays decision on Plan B, decision expected in May.  // Contemporary Sexuality;Mar2004, Vol. 38 Issue 3, p7 

    This article reports on the delay in the U.S. Food and Drug Administration (FDA) decision for the emergency contraceptive Plan B. The federal agency says it wants more data from the manufacturer of the drug on how it affects teenage girls. But advocates of birth control are concerned that the...

  • History of Birth Control in the United States.  // Congressional Digest;Apr2012, Vol. 91 Issue 4, p98 

    The article offers information on the history of U.S. birth control. It highlights the Comstock Act in 1873 that made mailing of obscene, lewd, and/or lascivious materials illegal and the commission established by Pope John XXIII in 1963 to study questions of population and birth control. It...

  • OTC access to EC blocked -- What's next?  // Contraceptive Technology Update;Feb2012, Vol. 33 Issue 2, p15 

    The article states that U.S. Health and Human Services secretary Kathleen Sebelius overruled a decision by the Food and Drug Administration to allow over-the-counter access to the emergency contraceptive Plan B One-Step.

  • 2nd office-based system OK'd for sterilization.  // Same-Day Surgery;Dec2009, Vol. 33 Issue 12, p126 

    The article reports that the U.S. Food and Drug Administration has approved the Adiana permanent contraception system, which is an office-based procedure that provides permanent birth control in women.

  • Emergency contraception: Living up to its promise? Melby, Todd // Contemporary Sexuality;May2009, Vol. 43 Issue 5, p1 

    The article focuses on emergency contraception and the reasons for why it has not been used as much as experts believed it would be. Factors include the difficulty in gaining access to the drug, which has been marketed under the brand name Plan B. The U.S. Food and Drug Administration (FDA)...

  • New FDA Approvals.  // Drug Utilization Review;Feb2002, Vol. 18 Issue 2, p8 

    Presents updates related to the United States Food and Drug Administration drug approvals as of February 2002, citing the approval for Fondaparinux sodium.

  • Final DSHEA rules may be delayed.  // Drug Store News;8/5/96, Vol. 18 Issue 12, p32 

    Reports that the Dietary Supplement Health and Education Act of 1994 freed pharmaceutical manufacturers to communicate product benefits to consumers and put the burden on the Food and Drug Administration to prove products unsafe.

  • Accelerated approvals examined. Dorey, Emma // Nature Biotechnology;Mar2011, Vol. 29 Issue 3, p176 

    The article reports on the decision of the U.S. Food and Drug Administration (FDA) to review several drugs approved under the much-criticized accelerated approval program in March 2011, which include Amgen's Vectibix, Genzyme's Clolar and GlaxoSmithKline's Bexxar.

  • Opinion: A proposal for FDA reform. Miller, Henry I. // Nature Reviews Drug Discovery;Aug2002, Vol. 1 Issue 8, p642 

    Since the current system for the regulation of drugs in the United States was established in 1962, the FDA has steadily increased the scope of its responsibilities and activities, and, concomitantly, the regulatory burden on drug developers. The costs and time that are required for drug...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics